These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 15778267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes.
    Hüneke R, Jüngling E, Skasa M, Rossaint R, Lückhoff A.
    Anesthesiology; 2001 Oct; 95(4):999-1006. PubMed ID: 11605944
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol.
    Yamakura T, Harris RA.
    Anesthesiology; 2000 Oct; 93(4):1095-101. PubMed ID: 11020766
    [Abstract] [Full Text] [Related]

  • 5. G-protein activation decreases isoflurane inhibition of N-type Ba2+ currents.
    Nikonorov IM, Blanck TJ, Recio-Pinto E.
    Anesthesiology; 2003 Aug; 99(2):392-9. PubMed ID: 12883412
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Isoflurane inhibits neuronal Ca2+ channels through enhancement of current inactivation.
    Kameyama K, Aono K, Kitamura K.
    Br J Anaesth; 1999 Mar; 82(3):402-11. PubMed ID: 10434825
    [Abstract] [Full Text] [Related]

  • 8. G-protein activation decreases the isoflurane inhibition of N-type Ca2+ currents. An increase in the isoflurane blocking potency of N-type Ca2+ currents may contribute to the known neuroprotection action of isoflurane during ischemia.
    Recio-Pinto E, Nikonorov IM, Blanck TJ.
    J Neurosurg Anesthesiol; 2004 Jan; 16(1):105-7. PubMed ID: 14676582
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depression by isoflurane of the action potential and underlying voltage-gated ion currents in isolated rat neurohypophysial nerve terminals.
    Ouyang W, Hemmings HC.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):801-8. PubMed ID: 15375177
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accelerated inactivation of cardiac L-type calcium channels triggered by anaesthetic-induced preconditioning.
    Tampo A, Hogan CS, Sedlic F, Bosnjak ZJ, Kwok WM.
    Br J Pharmacol; 2009 Feb; 156(3):432-43. PubMed ID: 19154423
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The haemodynamic and catecholamine response to xenon/remifentanil anaesthesia in Beagle dogs.
    Francis RC, Reyle-Hahn MS, Höhne C, Klein A, Theruvath I, Donaubauer B, Busch T, Boemke W.
    Lab Anim; 2008 Jul; 42(3):338-49. PubMed ID: 18625589
    [Abstract] [Full Text] [Related]

  • 17. Isoform-selective effects of isoflurane on voltage-gated Na+ channels.
    OuYang W, Hemmings HC.
    Anesthesiology; 2007 Jul; 107(1):91-8. PubMed ID: 17585220
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.
    Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R.
    Anesthesiology; 2013 Nov; 119(5):1137-48. PubMed ID: 23867231
    [Abstract] [Full Text] [Related]

  • 19. Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals.
    Ouyang W, Wang G, Hemmings HC.
    Mol Pharmacol; 2003 Aug; 64(2):373-81. PubMed ID: 12869642
    [Abstract] [Full Text] [Related]

  • 20. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
    Fujita H, Ogura T, Tamagawa M, Uemura H, Sato T, Ishida A, Imamaki M, Kimura F, Miyazaki M, Nakaya H.
    Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.